본문 바로가기

Effect of Single-Nucleotide Polymorphisms on Decline of Dopamine Transporter Availability in Parkinson's Disease

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q2
저널
JOURNAL OF CLINICAL NEUROLOGY15(1) · pp.102 · 2019
피인용
Web of Science 7Scopus 7KCI 0
FWCI (Scopus)
0.24
JCR IF
JCR 2018 2.796
ISSN
1738-6586

저자

  1. 신승현제1저자Department of Nuclear Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  2. 김근영Department of Nuclear Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  3. 이재민Department of ‌Neurosurgery, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  4. 김은주Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  5. 김성장Department of Nuclear Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University, Yangsan Hospital, Yangsan, South Korea
  6. 김인주교신저자Department of Nuclear Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  7. 박경준Department of Nuclear Medicine, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  8. 이명준Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea

초록

Background and Purpose We aimed to determine the association between the annual changes in dopamine transporter (DAT) availability as measured by I-123-ioflupane (I-123-FP-CIT) single-photon-emission computed tomography and single-nucleotide polymorphisms (SNPs) known to be risk factors in Parkinson's disease (PD). Methods In total, 150 PD patients were included from the Parkinson's Progression Markers Initiative database. Specific SNPs that are associated with PD were selected for genotyping. SNPs that were not in Hardy-Weinberg equilibrium or whose minor allele frequency was less than 0.05 were excluded. Twenty-three SNPs met the inclusion criteria for this study. The Kruskal-Wallis test was used to compare annual percentage changes in DAT availability for three subgroups of SNP. Results None of the 23 SNPs exerted a statistically significant effect (p<0.0022) on the decline of DAT availability in PD patients. However, we observed trends of association (p<0.05) between three SNPs of two genes with the annual percentage change in DAT availability: 1) rs199347 on the putamen (p=0.0138), 2) rs356181 on the caudate nucleus (p=0.0105), and 3) rs3910105 on the caudate nucleus (p=0.0374). A post-hoc analysis revealed that DAT availability was reduced the most for 1) the putamen in the CC genotype of rs199347 (vs. CT, p=0.0199; vs. TT, p= 0.0164), 2) the caudate nucleus in the TT genotype of rs356181 (vs. CC, p=0.0081), and 3) the caudate nucleus in the CC genotype of rs3910105 (vs. TT, p=0.0317). Conclusions Significant trends in the associations between three SNPs and decline of DAT availability in PD patients have been discovered.

키워드

single photon emission computed tomographyI-123-ioflupanedopamine transportersingle-nucleotide polymorphismParkinson's diseaseSNCA GENESPECTRISKMETAANALYSISEXPRESSIONGPNMB

식별자

Scopus EID
2-s2.0-85060992450
WoS UID
000455857100014
KCI
ART002428384